2m 2m 2m 2m 2m 2m 2m
Aclaris Therap (ACRS)
NASDAQ
$4.48-$0.15 (-3.26%)
Price as of Jun 03, 2026 7:58 PM EDT- $635.5MMarket Cap
- 214.97%1-Year Change
- BiotechnologyIndustry
Aclaris Therap (ACRS)
$4.48-$0.15 (-3.26%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BML CAPITAL MANAGEMENT, LLC | 11.82% | 14.3M | 0 (0.00%) | Mar 31, 2026 |
DEEP TRACK CAPITAL, LP | 7.75% | 9.3M | +9.3M (+100.00%) | Mar 31, 2026 |
BLACKROCK, INC. | 6.14% | 7.4M | +602,224 (+8.13%) | Mar 31, 2026 |
RA CAPITAL MANAGEMENT, L.P. | 5.64% | 6.8M | +6.8M (+100.00%) | Mar 31, 2026 |
VIVO CAPITAL, LLC | 5.53% | 6.7M | -2.2M (-33.33%) | Mar 31, 2026 |
VANGUARD GROUP INC | 5.39% | 6.5M | -13,378 (-0.21%) | Dec 31, 2025 |
WELLINGTON MANAGEMENT CO LLP | 4.59% | 5.5M | +118,815 (+2.14%) | Dec 31, 2021 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FIDELITY CONCORD STREET TRUST | 0.78% | 942,424 | -19,434 (-2.06%) | Feb 28, 2026 |
VANGUARD SCOTTSDALE FUNDS | 0.44% | 529,599 | +39,546 (+7.47%) | Feb 28, 2026 |
HARTFORD MUTUAL FUNDS INC/CT | 0.40% | 487,136 | 0 (0.00%) | Jan 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 0.36% | 435,589 | 0 (0.00%) | Feb 28, 2026 |
MAINSTAY FUNDS TRUST | 0.30% | 359,258 | 0 (0.00%) | Jan 31, 2026 |
BRIDGEWAY FUNDS INC | 0.26% | 317,019 | 0 (0.00%) | Mar 31, 2026 |
SCHWAB CAPITAL TRUST | 0.24% | 284,604 | +42,648 (+14.99%) | Jan 31, 2026 |
Current Ownership Distribution
- Institutions1.3B (87.48%)
- Mutual Funds164.1M (10.92%)
- Insiders24.0M (1.60%)
- Other0 (0.00%)
Insider Transactions
- 1.60% (24.0M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 1Number of InsiderSelling (last 12 months)
- $61.8MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Leonard Braden Michael | Sell | Apr 23, 2026 | $1.4M | 300,000 | $4.53 | 13.9M |
Balthaser Kevin Chief Financial Officer | Exempt | Feb 03, 2026 | $0.00 | 22,025 | $0.00 | 66,075 |
Walker Neal CEO | Exempt | Feb 03, 2026 | $0.00 | 63,475 | $0.00 | 190,425 |
Davis Hugh M. President and COO | Exempt | Feb 03, 2026 | $0.00 | 18,675 | $0.00 | 56,025 |
Walker Neal CEO | Exempt | Feb 03, 2026 | $0.00 | 63,475 | $0.00 | 1.6M |
Balthaser Kevin Chief Financial Officer | Exempt | Feb 03, 2026 | $0.00 | 22,025 | $0.00 | 192,204 |
Walker Neal CEO | In Kind | Feb 03, 2026 | $64,580.17 | 18,611 | $3.47 | 1.5M |
Davis Hugh M. President and COO | Exempt | Feb 03, 2026 | $0.00 | 18,675 | $0.00 | 45,425 |
Balthaser Kevin Chief Financial Officer | In Kind | Feb 03, 2026 | $22,378.03 | 6,449 | $3.47 | 185,755 |
Hall Jesse Wayne Chief Medical Officer | Award | Feb 02, 2026 | $0.00 | 98,100 | $0.00 | 98,100 |
Loerop James Chief Business Officer | Award | Feb 02, 2026 | $0.00 | 97,700 | $0.00 | 97,700 |
Kolbeck Roland Wilhelm Chief Scientific Officer | Award | Feb 02, 2026 | $0.00 | 95,700 | $0.00 | 95,700 |
Walker Neal CEO | Award | Feb 02, 2026 | $0.00 | 274,800 | $0.00 | 274,800 |
Hall Jesse Wayne Chief Medical Officer | Award | Feb 02, 2026 | $0.00 | 343,300 | $0.00 | 343,300 |
Davis Hugh M. President and COO | Award | Feb 02, 2026 | $0.00 | 96,100 | $0.00 | 96,100 |
Kolbeck Roland Wilhelm Chief Scientific Officer | Award | Feb 02, 2026 | $0.00 | 334,900 | $0.00 | 334,900 |
Walker Neal CEO | Award | Feb 02, 2026 | $0.00 | 961,700 | $0.00 | 961,700 |
Loerop James Chief Business Officer | Award | Feb 02, 2026 | $0.00 | 341,900 | $0.00 | 341,900 |
Davis Hugh M. President and COO | Award | Feb 02, 2026 | $0.00 | 336,300 | $0.00 | 336,300 |
Balthaser Kevin Chief Financial Officer | Exempt | Feb 01, 2026 | $0.00 | 14,750 | $0.00 | 29,500 |
Balthaser Kevin Chief Financial Officer | Exempt | Feb 01, 2026 | $0.00 | 14,750 | $0.00 | 175,163 |
Balthaser Kevin Chief Financial Officer | In Kind | Feb 01, 2026 | $17,493.84 | 4,984 | $3.51 | 170,179 |
Walker Neal CEO | Exempt | Jan 02, 2026 | $0.00 | 29,150 | $0.00 | 30,034 |
Loerop James Chief Business Officer | Exempt | Jan 02, 2026 | $0.00 | 18,150 | $0.00 | 18,700 |
Balthaser Kevin Chief Financial Officer | Exempt | Jan 02, 2026 | $0.00 | 13,200 | $0.00 | 13,600 |
Loerop James Chief Business Officer | Exempt | Jan 02, 2026 | $0.00 | 18,150 | $0.00 | 161,212 |
Walker Neal CEO | Exempt | Jan 02, 2026 | $0.00 | 29,150 | $0.00 | 1.5M |
Loerop James Chief Business Officer | In Kind | Jan 02, 2026 | $17,772.48 | 6,171 | $2.88 | 155,041 |
Balthaser Kevin Chief Financial Officer | Exempt | Jan 02, 2026 | $0.00 | 13,200 | $0.00 | 164,874 |
Walker Neal CEO | In Kind | Jan 02, 2026 | $28,661.76 | 9,952 | $2.88 | 1.5M |